In a strategic collaboration highlighting dedication to regulatory excellence and healthcare advancement, Eda, the Egyptian Drug Authority, is pleased to announce a specialized training initiative. The program, titled "Transitioning from Medical Device Directive (M.D.D.) to Medical Device Regulation (M.D.R.): Regulatory Training Course," was scheduled for October 2023, addressing a crucial shift in healthcare regulatory standards.

MediCure, acting as the sole agent for Innate Srl in Egypt, is an instrumental partner in this collaboration, underlining their commitment to providing top-notch healthcare solutions and complying with evolving regulations. This session distinctly emphasizes MediCure's dedication to its societal responsibilities.

This training initiative is meticulously crafted to equip the Eda team with comprehensive insights into the paradigm shift from the Medical Device Directive (M.D.D.) to the more stringent Medical Device Regulation (M.D.R.). It stands as a pivotal step in ensuring regulatory compliance and a profound understanding of the evolving healthcare landscape. One of the primary goals of this session is to ensure that Eda remains continually updated with the latest regulatory changes, further aligning with MediCure's commitment to societal welfare.

The distinguished speakers for this event are Dr. Massimo Inguglia, Commercial Manager at Innate Srl, and Dr. Giulia Avio, Regulatory Affairs Manager at Innate Srl. Their expertise and insights will guide the participants, shedding light on the intricacies of compliance with the new regulatory framework.

Dr. Noha El Hariri, General Manager of the Medical Device Department at Eda, emphasized the value of physical training in enhancing interactions among team members during such programs. This unique approach fosters a collaborative environment, ensuring a more enriching learning experience.

This collaborative training initiative not only marks a significant step in regulatory compliance but also highlights the strong partnership between Eda, MediCure, and Innate Srl. It underlines their joint commitment to excellence in healthcare practices and continuous professional development.

As the event approaches, there is a sense of enthusiasm and eagerness to gain insights into the changing regulatory landscape. Eda and Innate Srl encourage all participants to actively engage and make the most of this educational opportunity. Stay tuned for updates on similar collaborative educational initiatives aimed at furthering knowledge and expertise within the healthcare industry.